Skip to main content

Table 2 Intervention components present in DNA and non-DNA risk assessment arms

From: Trial Protocol: Communicating DNA-based risk assessments for Crohn's disease: a randomised controlled trial assessing impact upon stopping smoking

Intervention component

DNA arm

Non-DNA arm

Mouthwash posted to participant to collect saliva sample for NOD2 Genotyping

√

X

Booklet containing results of risk assessment posted approximately 6 weeks after initial contact

√

√

Personal risk presented using a numerical risk with a denominator of 1000, accompanied by a visual display

√

√

Feedback of risk assessment based on family history of CD and smoking Status

√

√

Feedback of risk assessment based on NOD2 genotype

√

X

Explanation of NOD2 gene in booklet

√

X

Explanation of how stopping smoking reduces the risk of CD in booklet

√

√

Smoking cessation advice over the telephone

√

√